For: | Lu ZY, Shao Z, Li YL, Wulasihan M, Chen XH. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study. World J Gastroenterol 2016; 22(13): 3663-3669 [PMID: 27053858 DOI: 10.3748/wjg.v22.i13.3663] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i13/3663.htm |
Number | Citing Articles |
1 |
Qianli Yuan, Huai Wang, Pei Gao, Weixin Chen, Min Lv, Shuang Bai, Jiang Wu. Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease among 73,566 Individuals in Beijing, China. International Journal of Environmental Research and Public Health 2022; 19(4): 2096 doi: 10.3390/ijerph19042096
|
2 |
Zhu Chen, Chunmei Li, Caixia Yang, Ronghua Zhao, Xiaojian Mao, Jie Yu. Lipid Regulation Effects of Raw and Processed Notoginseng Radix Et Rhizome on Steatotic Hepatocyte L02 Cell. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/2919034
|
3 |
Yuan Li, Shousheng Liu, Yuqiang Gao, Huan Ma, Shuhui Zhan, Yan Yang, Yongning Xin, Shiying Xuan. Association of TM6SF2 rs58542926 gene polymorphism with the risk of non-alcoholic fatty liver disease and colorectal adenoma in Chinese Han population. BMC Biochemistry 2019; 20(1) doi: 10.1186/s12858-019-0106-3
|
4 |
Chien-Chih Chen, Wei-Chien Hsu, Han-Ming Wu, Jiun-Yi Wang, Pei-Yu Yang, I-Ching Lin. Association between the Severity of Nonalcoholic Fatty Liver Disease and the Risk of Coronary Artery Calcification. Medicina 2021; 57(8): 807 doi: 10.3390/medicina57080807
|
5 |
Tianqi Xu, Li Wang, Na Chang, Sha Li, Bingxuan Jiao, Shuai Zhang, Ximing Wang. CT-Diagnosed Non-Alcoholic Fatty Liver Disease as a Risk Predictor of Symptomatic Carotid Plaque and Cerebrovascular Symptoms. Angiology 2024; doi: 10.1177/00033197241227501
|
6 |
Chunmei Yang, Tingwan Du, Yueying Zhao, Youhui Qian, Jiashi Tang, Xiaohong Li, Ling Ma. Development and Validation of a Risk Prediction Model for NAFLD: A Study Based on a Physical Examination Population. Diabetes, Metabolic Syndrome and Obesity 2024; : 143 doi: 10.2147/DMSO.S438652
|
7 |
Bertrand Cariou, Christopher D. Byrne, Rohit Loomba, Arun J. Sanyal. Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review. Diabetes, Obesity and Metabolism 2021; 23(5): 1069 doi: 10.1111/dom.14322
|
8 |
Huiyul Park, Kye-Yeung Park, Minki Kim, Hoon-Ki Park, Hwan-Sik Hwang. Association between serum uric acid level and non-alcoholic fatty liver disease in Koreans. Asian Biomedicine 2022; 16(1): 15 doi: 10.2478/abm-2022-0003
|
9 |
Jianping Yang, Qinzhi Wei, Xiaochun Peng, Xiaowu Peng, Jianhui Yuan, Dalin Hu. Relationship between Methyl Tertiary Butyl Ether Exposure and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Petrol Station Attendants in Southern China. International Journal of Environmental Research and Public Health 2016; 13(10): 946 doi: 10.3390/ijerph13100946
|
10 |
Hui Zhao, Bin Hu. Risk Factors for Non-alcoholic Fatty Liver Disease in Chinese Population: A Five-year Follow-up Study. Iranian Red Crescent Medical Journal 2019; 21(7) doi: 10.5812/ircmj.91064
|
11 |
Jie Mu, Xueqian Wang, Qingguo Wang, Fafeng Cheng, Wenxiang Zhu, Changxiang Li, Chongyang Ma, Changming Zhai, Yajun Lian, Xin Du. Molecular mechanism of non-alcoholic fatty liver disease induced and aggravated by chronic stress through HSL/ATGL-FFA which promotes fat mobilization. Journal of Traditional Chinese Medical Sciences 2019; 6(4): 315 doi: 10.1016/j.jtcms.2019.08.001
|
12 |
Zhixiong Ying, Robin van Eenige, Xiaoke Ge, Christy van Marwijk, Joost M. Lambooij, Bruno Guigas, Martin Giera, Jan Freark de Boer, Tamer Coskun, Hongchang Qu, Yanan Wang, Mariëtte R. Boon, Patrick C.N. Rensen, Sander Kooijman. Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP mice. eBioMedicine 2023; 93: 104684 doi: 10.1016/j.ebiom.2023.104684
|
13 |
Yang Zou, Meng Yu, Guotai Sheng. Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: a prospective cohort study. Lipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01326-3
|
14 |
Yuxian Yang, Shuting Li, Yuechao Xu, Jing Ke, Dong Zhao. The Perirenal Fat Thickness Was Associated with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; : 1505 doi: 10.2147/DMSO.S350579
|
15 |
Hong-Ye Peng, Shao-Jie Duan, Liang Pan, Mi-Yuan Wang, Jia-Liang Chen, Yi-Chong Wang, Shu-Kun Yao. Development and validation of machine learning models for nonalcoholic fatty liver disease. Hepatobiliary & Pancreatic Diseases International 2023; 22(6): 615 doi: 10.1016/j.hbpd.2023.03.009
|
16 |
Wenyu Wu, Haiyan Liao, Weilin Ye, Xi Li, Jian Zhang, Junguo Bu. Fatty liver is a risk factor for liver metastasis in Chinese patients with non-small cell lung cancer. PeerJ 2019; 7: e6612 doi: 10.7717/peerj.6612
|
17 |
Judith Aron-Wisnewsky, Chloé Vigliotti, Julia Witjes, Phuong Le, Adriaan G. Holleboom, Joanne Verheij, Max Nieuwdorp, Karine Clément. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nature Reviews Gastroenterology & Hepatology 2020; 17(5): 279 doi: 10.1038/s41575-020-0269-9
|
18 |
Hwi Jin Im, Yo Chan Ahn, Jing-Hua Wang, Myung Min Lee, Chang Gue Son. Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea. Clinics and Research in Hepatology and Gastroenterology 2021; 45(4): 101526 doi: 10.1016/j.clinre.2020.06.022
|
19 |
Ting Bao, Zhiye Ying, Li Gong, Jing Du, Guiyi Ji, Zhengzheng Li, Wei Gao, Xianweng Jiang, Hanwei Yang, Yan Huang, Huairong Tang. Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Nonobese Postmenopausal Women: A Cross-sectional Study. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-66931-9
|
20 |
Iñaki Milton-Laskibar, Amanda Cuevas-Sierra, María P. Portillo, J. Alfredo Martínez. Effects of Resveratrol Administration in Liver Injury Prevention as Induced by an Obesogenic Diet: Role of Ruminococcaceae. Biomedicines 2022; 10(8): 1797 doi: 10.3390/biomedicines10081797
|
21 |
Yu-Chen Guo, Yong Zhou, Xing Gao, Yan Yao, Bin Geng, Qing-Hua Cui, Ji-Chun Yang, Hong-Pu Hu. Association between Nonalcoholic Fatty Liver Disease and Carotid Artery Disease in a Community-Based Chinese Population. Chinese Medical Journal 2018; 131(19): 2269 doi: 10.4103/0366-6999.241797
|
22 |
Wei-Wei Sun, Tao ShangGuan, Ping Zhu, Hua-Kang Li, Min Jiang, Pan Yang, Lin-Yu Li, Zhi-Hui Zhang. RETRACTED: Role of hepatic neuropeptide Y-Y1 receptors in a methionine-cholinedeficient model of non-alcoholic steatohepatitis. Life Sciences 2020; 245: 117356 doi: 10.1016/j.lfs.2020.117356
|
23 |
Ren Lin, Dan Wu, Feng-Juan Wu, Yuan Meng, Jin-Heng Zhang, Xiao-Gang Wang, Li-Hong Jia. Non-alcoholic Fatty Liver Disease Induced by Perinatal Exposure to Bisphenol a Is Associated With Activated mTOR and TLR4/NF-κB Signaling Pathways in Offspring Rats. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00620
|
24 |
Emma Purón-González, Arnulfo González-Cantú, Edgar Ulises Coronado-Alejandro, Oswaldo Enrique Sánchez-Dávila, Héctor Cobos-Aguilar, Maria Elena Romero-Ibarguengoitia. Predictive markers of nonalcoholic fatty liver disease in lean patients. A multinomial regression model and a 2k factorial analysis. European Journal of Gastroenterology & Hepatology 2021; 33(10): 1316 doi: 10.1097/MEG.0000000000001845
|
25 |
Juanwen Zhang, Xuyao Zhang, Ying Zhao, Guocai Lv. Association Between Urinary Alpha1-Microglobulin Levels and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study. Annals of Nutrition and Metabolism 2018; 72(1): 30 doi: 10.1159/000484255
|
26 |
Stephanie Chen, Samantha Chao, Monica Konerman, Wei Zhang, Huiying Rao, Elizabeth Wu, Andy Lin, Lai Wei, Anna S. Lok. Survey of Nonalcoholic Fatty Liver Disease Knowledge, Nutrition, and Physical Activity Patterns Among the General Public in Beijing, China. Digestive Diseases and Sciences 2019; 64(12): 3480 doi: 10.1007/s10620-019-05709-0
|
27 |
Michael H. Le, Yee Hui Yeo, Xiaohe Li, Jie Li, Biyao Zou, Yuankai Wu, Qing Ye, Daniel Q. Huang, Changqing Zhao, Jie Zhang, Chenxi Liu, Na Chang, Feng Xing, Shiping Yan, Zi Hui Wan, Natasha Sook Yee Tang, Maeda Mayumi, Xinting Liu, Chuanli Liu, Fajuan Rui, Hongli Yang, Yao Yang, Ruichun Jin, Richard H.X. Le, Yayun Xu, David M. Le, Scott Barnett, Christopher Donald Stave, Ramsey Cheung, Qiang Zhu, Mindie H. Nguyen. 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2022; 20(12): 2809 doi: 10.1016/j.cgh.2021.12.002
|
28 |
Ivan M. Petyaev, Pavel Y. Dovgalevsky, Natalia E. Chalyk, Victor A. Klochkov, Nigel H. Kyle, Yuriy K. Bashmakov. Reduction of Liver Span and Parameters of Inflammation in Nonalcoholic Fatty Liver Disease Patients Treated with Lycosome Formulation of Phosphatidylcholine: A Preliminary Report. International Journal of Chronic Diseases 2018; 2018: 1 doi: 10.1155/2018/4549614
|
29 |
Xiaofei Luo, Ying Li, Yi Zhou, Chun Zhang, Lijun Li, Yating Luo, Jiangang Wang, Yinglong Duan, Jianfei Xie. Association of Non-alcoholic Fatty Liver Disease With Salt Intake and Dietary Diversity in Chinese Medical Examination Adults Aged 18–59 Years: A Cross-Sectional Study. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.930316
|
30 |
Binxia Chang, Baosen Li, Ang Huang, Ying Sun, Guangju Teng, Xiaoxia Wang, Suthat Liangpunsakul, Jin Li, Zhengsheng Zou. Changes of four common non-infectious liver diseases for the hospitalized patients in Beijing 302 hospital from 2002 to 2013. Alcohol 2016; 54: 61 doi: 10.1016/j.alcohol.2016.07.001
|
31 |
Shuaiyin Zheng, Di Li, Zhuoyue Shi, Ying Yang, Lidan Li, Peidi Chen, Xieerwaniguli A bulimiti, Fuye Li. Development and validation of a nomogram for nonalcoholic fatty liver disease in Western Xinjiang, China. European Journal of Gastroenterology & Hepatology 2024; 36(10): 1220 doi: 10.1097/MEG.0000000000002807
|
32 |
Linxin Xu, Ting Li, Jianhong Yin, Gang Lin, Yali Xu, Yi Ren, Yan Wang, Jing Yang, Liming Chen. Association between serum uric acid and nonalcoholic fatty liver disease in community patients with type 2 diabetes mellitus. PeerJ 2019; 7: e7563 doi: 10.7717/peerj.7563
|